December 2, 2020

The Niche

Knoepfler lab stem cell blog

Carl Elliott

5 min read

Will the adipose stem cell clinic firms facing permanent injunction suits by the FDA — U.S. Stem Cell Inc. (USRM) and California Stem Cell Treatment Center (CSCTC)/Cell Surgical Network (CSN) — cool it in the sense of voluntarily shutting down their commercial fat stem cell injections of customers soon pending the outcomes of the suits? Or will things heat up further? In the interview I did last week with Patti Zettler she mentioned the possibility of a voluntary stop by the clinics. The more …Read More

5 min read

Professor Steven Pinker of Harvard has been making the case recently that when it comes to novel biotechnologies such as CRISPR-Cas9 that bioethics should just get out of the way. Further, he has argued that we do not need a moratorium on clinical use of CRISPR-Cas9 for human genetic modification. In fact, he says that such a moratorium would be harmful. I think he’s wrong about that. I’m not a bioethicist so rather than talk primarily about his views on bioethics, I’m going to …Read More

4 min read

Recently, there has been a brewing controversy surrounding a journal called American Journal of Bioethics (AJOB), a company called CellTex, a bioethicist named Dr. Glenn McGee who founded and used to run AJOB until he recently resigned, and two University of Minnesota professors, Drs. Carl Elliott and Leigh Turner who have been publicly critical of Celltex and/or McGee. Dr. Elliott wrote a piece in Slate, later retracted, that discussed McGee and Celltex. Dr. Turner, wrote a letter to the FDA describing his concerns about …Read More